RRP6L1 Antibody

What is RRP6L1 and why is it significant for plant stress response studies?

RRP6L1 is an RNA binding protein with established roles in small RNA production and RNA-directed DNA Methylation. The protein contains a 3'-5' exonuclease domain in its N-terminal region and a Helicase and RNase D C-terminal (HRDC) nucleic acid-binding domain in its C-terminal portion . Research has demonstrated that RRP6L1 knockout mutants maintain higher growth levels than wild type during moderate low water potential stress, similar to the phenotype observed in ahl10-1 mutants . This suggests RRP6L1 functions as a growth suppressor during drought stress. Transcriptome analyses further reveal that RRP6L1 affects the expression of stress-responsive genes, with substantial concordance between gene expression changes in rrp6l1 and ahl10 mutants .

What molecular weight should RRP6L1 antibodies detect in western blotting experiments?

RRP6L1 antibodies typically detect a protein band at approximately 77 kD, which corresponds to the expected molecular weight of full-length RRP6L1 protein . This was confirmed in studies using antisera generated against the N-terminal domain of RRP6L1, which successfully distinguished between wild type and RRP6L1 knockout mutants (rrp6l1-1 and rrp6l1-2), showing complete absence of the 77 kD band in the mutants . The specificity of this detection provides a crucial validation control for researchers developing or using RRP6L1 antibodies.

How does tissue type affect RRP6L1 detection with antibodies?

RRP6L1 protein levels exhibit substantial tissue specificity, with significantly higher accumulation in shoot and root meristem tissues compared to whole seedling samples . This tissue-specific expression pattern mirrors that of its interacting partner AHL10-YFP, providing evidence for their physical interaction in planta . Researchers should therefore prioritize meristem-enriched samples when designing experiments requiring high sensitivity for RRP6L1 detection. The localized expression pattern may explain why whole-seedling transcriptome analyses showed relatively modest changes in gene expression profiles in rrp6l1 mutants, as effects in specific tissues might be diluted in whole-plant samples .

How can RRP6L1 antibodies be optimized for chromatin immunoprecipitation studies?

For effective chromatin immunoprecipitation (ChIP) studies using RRP6L1 antibodies, several protocol optimizations are critical. First, researchers should focus on meristem-enriched tissues where RRP6L1 is highly expressed . The cross-linking step requires careful optimization, as RRP6L1 association with chromatin appears to be indirect through its interaction with DNA-binding proteins like AHL10 . Studies have shown that RRP6L1 chromatin recruitment depends on AHL10 and specifically on AHL10 S314 phosphorylation . Therefore, protocols should preserve protein-protein interactions through appropriate cross-linking conditions. Additionally, researchers should include phosphatase inhibitors in all buffers to maintain the phosphorylation status of interacting proteins like AHL10, which is critical for RRP6L1 chromatin association .

What approaches can reveal the phosphorylation-dependent interaction between RRP6L1 and AHL10?

To study the phosphorylation-dependent interaction between RRP6L1 and AHL10, researchers should employ a multi-faceted approach. In vitro pull-down assays have demonstrated that both the N-terminal (N300) and C-terminal (C337) fragments of RRP6L1 can interact with AHL10, with the C-terminal fragment showing significantly stronger interaction . Interestingly, phosphomimic mutations at the S313 and S314 phosphorylation sites of AHL10 increased pull-down band intensity with the N-terminal RRP6L1 fragment but had no significant effect on interaction with the C-terminal fragment . This suggests differential effects of phosphorylation on domain-specific interactions. For in vivo validation, researchers should perform co-immunoprecipitation experiments comparing wild-type plants with those expressing phosphomimic or phosphonull AHL10 variants under both normal and stress conditions, as RRP6L1 protein levels increase moderately under low water potential stress .

How should researchers generate and validate RRP6L1 antibodies for specific experimental applications?

When generating RRP6L1 antibodies, several critical considerations emerge from published research. Full-length RRP6L1 expression in E. coli has proven difficult, consistent with previous reports . Therefore, researchers should divide the protein into manageable fragments, such as the N-terminal 300 amino acids (containing the exonuclease domain) and C-terminal 337 amino acids (containing the HRDC domain) . In published studies, antisera generated against the N-terminal domain successfully detected the 77 kD full-length protein in western blotting . Validation should always include known RRP6L1 knockout mutants as negative controls, such as rrp6l1-1 and rrp6l1-2, which should show complete absence of signal . Additional validation approaches should include immunoblotting of recombinant protein fragments and testing antibody performance in immunoprecipitation before proceeding to more complex applications.

How does RRP6L1 function relate to its interacting partner AHL10 in stress response pathways?

Research indicates that RRP6L1 and AHL10 function together in regulating plant growth during water stress . Both rrp6l1 mutants and ahl10-1 maintained higher growth levels than wild type during moderate low water potential stress, while an ahl10-1rrp6l1-2 double mutant showed similar increased growth maintenance as either single mutant . This non-additive effect strongly suggests they function in the same pathway. At the molecular level, AHL10 phosphorylation at S314 is required for RRP6L1 chromatin association . These proteins appear to co-regulate an overlapping set of genes, as transcriptome analyses revealed substantial concordance between gene expression changes in rrp6l1-2 and ahl10-1, with particular agreement for genes showing decreased expression in both mutants . When designing experiments to study this relationship, researchers should include phosphorylation site mutants of AHL10 (S314A phosphonull and S314D phosphomimic) to elucidate how phosphorylation-dependent interactions affect RRP6L1 function.

What control samples are essential when using RRP6L1 antibodies in protein-protein interaction studies?

For protein-protein interaction studies involving RRP6L1 antibodies, several control samples are essential. First, genetic controls should include RRP6L1 knockout mutants (rrp6l1-1, rrp6l1-2) to validate antibody specificity . When studying the interaction with AHL10, researchers should include ahl10 mutants, and ideally the ahl10-1rrp6l1-2 double mutant . Protein abundance controls are also important, as research has shown that RRP6L1 protein level is not substantially affected in ahl10-1 and, conversely, AHL10 protein level is not substantially affected in rrp6l1-2 . This indicates that while the proteins functionally interact, they do not affect each other's stability or expression. Additionally, when studying phosphorylation-dependent interactions, include samples treated with phosphatase inhibitors versus phosphatase treatment to manipulate phosphorylation status, and compare with plants expressing phosphorylation site mutants of AHL10.

How should transcriptome data from rrp6l1 mutants be analyzed to understand RRP6L1 function?

Transcriptome analysis of rrp6l1 mutants provides valuable insights into RRP6L1 function. Under unstressed conditions, 294 genes (147 increased, 147 decreased) showed differential expression in rrp6l1-2 compared to wild type . Many of these genes had the same direction of expression change in ahl10-1, albeit often with weaker effects, supporting the concept that AHL10 and RRP6L1 act together in gene regulation . Genes with increased expression in unstressed rrp6l1-2 were enriched for GO terms related to abiotic stress or environmental stimuli, suggesting that RRP6L1 normally prevents aberrant expression of these genes under normal conditions . Under stress conditions, fewer genes showed differential expression in rrp6l1-2, but still with substantial concordance with ahl10-1 . When analyzing such data, researchers should focus particularly on meristem-specific genes, as both proteins show high expression in meristem tissues . Validation of key differentially expressed genes by qPCR is essential, as was done for RdR3 and RdR4 in published research .

Why might RRP6L1 antibodies show inconsistent detection in western blotting experiments?

Inconsistent RRP6L1 detection in western blotting can stem from several factors. The tissue-specific expression pattern is a primary consideration - RRP6L1 shows substantially higher levels in meristem tissues compared to whole seedlings . Therefore, sample type significantly affects detection sensitivity. Additionally, RRP6L1 protein levels increase moderately under low water potential stress, so experimental conditions and timing of sample collection may impact detection . Full-length RRP6L1 (77 kD) can be challenging to express and purify from E. coli , which may complicate the generation of high-quality antibodies and protein standards. To troubleshoot detection issues, researchers should optimize protein extraction using fresh tissue with protease and phosphatase inhibitors, adjust transfer conditions for efficient transfer of higher molecular weight proteins, and validate antibody specificity using rrp6l1 knockout mutants as negative controls .

How can researchers differentiate between direct and indirect effects of RRP6L1 on gene expression?

Differentiating between direct and indirect effects of RRP6L1 on gene expression requires integrated approaches. RRP6L1 has proposed functions in small RNA production and RNA-directed DNA Methylation , suggesting it may affect gene expression through epigenetic mechanisms. To determine direct targets, researchers should combine RRP6L1 ChIP-seq with RNA-seq from the same tissue types and conditions. Given that RRP6L1 chromatin association depends on phosphorylated AHL10 , researchers should also consider how this interaction impacts target specificity. The research noted that RRP6L1 and AHL10 are particularly abundant in meristem tissues, which may explain their effects on meristem-specific genes like STM and auxin-related genes such as WES1 and DFL1 . Therefore, tissue-specific analyses are crucial to avoid dilution effects. Additionally, time-course experiments following RRP6L1 recruitment to chromatin and subsequent gene expression changes can help establish causality. Comparing these patterns in wild type versus ahl10 phosphorylation site mutants can further elucidate the mechanism of RRP6L1-mediated gene regulation.

What factors might affect RRP6L1 antibody performance in different experimental contexts?

Multiple factors can influence RRP6L1 antibody performance across experimental contexts. The epitope accessibility may vary depending on RRP6L1's interaction with other proteins - research has demonstrated its interaction with AHL10 and potentially other proteins such as the C-Terminal Domain of NRPE1 . Conformational changes upon binding to these partners might mask epitopes recognized by certain antibodies. Post-translational modifications could also affect epitope recognition - although RRP6L1 itself may not be phosphorylated, its interaction with phosphorylated AHL10 suggests it functions in phosphorylation-responsive pathways . The research noted that RRP6L1 interaction with AHL10 could precede or be required for interaction with other proteins like the NRPE1 CTD , suggesting complex formation might alter antibody accessibility. Additionally, experimental conditions that preserve protein-protein interactions (like crosslinking parameters) will significantly impact antibody performance in techniques like ChIP or co-immunoprecipitation. Researchers should validate antibodies in each specific application and consider using multiple antibodies targeting different epitopes to ensure comprehensive detection.

How might RRP6L1 antibodies contribute to understanding the relationship between RNA processing and stress response?

RRP6L1 antibodies offer powerful tools to explore the mechanistic link between RNA processing and plant stress adaptation. Research has established that RRP6L1 affects the expression of stress-responsive genes and restricts growth during low water potential stress , but the precise mechanism remains unclear. Future studies could use RRP6L1 antibodies for RNA immunoprecipitation followed by sequencing (RIP-seq) to identify the RNA targets directly bound by RRP6L1 during stress conditions. This could reveal whether RRP6L1 processes specific stress-responsive transcripts or non-coding RNAs that regulate stress adaptation. The finding that genes with decreased expression in rrp6l1-2 include RNA-Dependent RNA Polymerase 3 (RdR3) and RdR4 suggests connections to small RNA pathways that could be explored through integrated analyses of RRP6L1 binding, small RNA production, and DNA methylation patterns under stress conditions. Additionally, the phosphorylation-dependent interaction between RRP6L1 and AHL10 points to a regulatory mechanism that could link stress signaling through protein kinases/phosphatases to RNA processing machinery.

What methodological advances could improve the utility of RRP6L1 antibodies in plant stress biology?

Several methodological advances could enhance RRP6L1 antibody applications in stress biology research. Development of monoclonal antibodies with defined epitopes within different RRP6L1 domains would allow more precise analysis of protein interactions and conformational changes under stress conditions. Given the tissue-specific expression of RRP6L1 in meristems , techniques for tissue-specific immunoprecipitation would significantly improve signal-to-noise ratio in binding studies. Implementation of quantitative proteomics with RRP6L1 immunoprecipitation could identify stress-specific protein interactions beyond the known AHL10 partnership . Development of proximity-labeling approaches using RRP6L1 antibodies would enable identification of the protein neighborhood in different cellular compartments and stress conditions. Advances in single-cell techniques could allow analysis of RRP6L1 function with cellular resolution in complex tissues like meristems, where RRP6L1 is highly expressed . Finally, combining RRP6L1 antibodies with nascent RNA labeling techniques would provide mechanistic insights into how RRP6L1-mediated RNA processing affects transcriptional dynamics during stress adaptation.